甲胎蛋白在非肝脏消化系统肿瘤中的研究进展
Progress of Alpha-Fetoprotein-Positive in Non-Hepatic Digestive System Tumors
DOI: 10.12677/ACM.2022.12111549, PDF,   
作者: 任晫煦, 孔繁娇, 郝 帅, 罗羽杉, 田亚文, 赵梓棋, 豆文丽：西安医学院，陕西 西安；贺 娜, 刘凯歌：西安医学院第一附属医院，陕西 西安
关键词: 甲胎蛋白；消化系统肿瘤；临床特征；治疗；Alpha-Fetoprotein-Positive； Digestive System Tumor； Clinical Characteristic； Treatment
摘要: 甲胎蛋白阳性的非肝脏消化系统肿瘤是一组具有相似病理特征的疾病，较普通消化道肿瘤更易发生淋巴道和远处转移，恶性程度及侵袭性更高。国内外多项研究发现，甲胎蛋白在疾病筛查、疗效评价和预后判断中发挥重要作用，但关于这类肿瘤的发病机制、诊断标准及治疗等方面的研究有限。在这篇综述中，我们讨论了甲胎蛋白在非肝脏消化系统肿瘤中的研究进展，为临床诊断及治疗提供参考。
Abstract: Alpha-fetoprotein-positive carcinoma from non-hepatic digestive system is a group of diseases with similar pathological characteristics, compared with common digestive tract tumor, which is more prone to lymphatic and distant metastasis, higher degree of malignancy and aggressiveness. A num-ber of studies at home and abroad have found that, alpha-fetoprotein plays an important role in disease screening, efficacy evaluation and prognosis judgment. However, the pathogenesis, diag-nostic criteria and treatment research of this tumor is limited. This review discusses the progress of alpha-fetoprotein-positive in non-hepatic digestive system tumors to provide a reference for clinical diagnosis and treatment.
文章引用：任晫煦, 贺娜, 孔繁娇, 郝帅, 罗羽杉, 田亚文, 赵梓棋, 豆文丽, 刘凯歌. 甲胎蛋白在非肝脏消化系统肿瘤中的研究进展[J]. 临床医学进展, 2022, 12(11): 10753-10758. https://doi.org/10.12677/ACM.2022.12111549

参考文献

[1] Mao, F.-Y., Kong, H., Zhao, Y.-L., et al. (2017) Increased Tumor-Infiltrating CD45RA−CCR7− Regulatory T-Cell Subset with Immunosuppressive Properties Foster Gastric Cancer Progress. Cell Death & Disease, 8, e3002. [Google Scholar] [CrossRef] [PubMed]
[2] Bourreille, J., Metayer, P., Sauger, F., Matray, F. and Fondimare, A. (1970) Existence of α-Fetoprotein during Gastric-Origin Secondary Cancer of the Liver. La Presse Médicale, 78, 1277-1278. (In French)
[3] Hirajima, S., Komatsu, S., Ichikawa, D., et al. (2013) Liver Metastasis Is the Only Inde-pendent Prognostic Factor in AFP-Producing Gastric Cancer. World Journal of Gastroenterology, 19, 6055-6061. [Google Scholar] [CrossRef] [PubMed]
[4] Wang, D., Li, C., Xu, Y., Xing, Y., Qu, L., Guo, Y., et al. (2015) Clinicopathological Characteristics and Prognosis of Alpha-Fetoprotein Positive Gastric Cancer in Chinese Patients. International Journal of Clinical and Experimental Pathology, 8, 6345-6355.
[5] Feng, Y., Li, Y., Dai, W., Mo, S., Li, Q., et al. (2018) Clinicopathologic Features and Prognostic Factors in Alpha- Fetoprotein-Producing Colorectal Cancer: Analysis of 78 Cases. Cellular Physiology and Biochemistry, 51, 2052-2064. [Google Scholar] [CrossRef] [PubMed]
[6] Kinjo, T., Taniguchi, H., Kushima, R., Sekine, S., Oda, I., et al. (2012) Histologic and Immunohistochemical Analyses of α-Fetoprotein—Producing Cancer of the Stomach. The American Journal of Surgical Pathology, 36, 56-65. [Google Scholar] [CrossRef] 
[7] Zheng, Y., Zhu, M. and Li, M. (2020) Effects of Al-pha-Fetoprotein on the Occurrence and Progression of Hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology, 146, 2439-2446. [Google Scholar] [CrossRef] [PubMed]
[8] Sentani, K., Uraoka, N., Oue, N., et al. (2014) Al-pha-Fetoprotein-Producing Clear Cell Carcinoma of the Gallbladder with Neuroendocrine Differentiation. Medical Molecular Morphology, 47, 54-56. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, Q., Liu, B., Qiao, W., et al. (2021) The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma after Locoregional Therapy: A 5-Year Prospective Cohort Study. Frontiers in Oncology, 11, Article 756363. [Google Scholar] [CrossRef] [PubMed]
[10] Yamamura, N. and Kishimoto, T. (2012) Epigenetic Regulation of GATA4 Expression by Histone Modification in AFP-Producing Gastric Adenocarcinoma. Experimental & Molecular Pathology, 93, 35-39. [Google Scholar] [CrossRef] [PubMed]
[11] Kamei, S., Kono, K., Amemiya, H., et al. (2003) Evaluation of VEGF and VEGF-C Expression in Gastric Cancer Cells Producing α-Fetoprotein. Journal of Gastroenterology, 38, 540-547. [Google Scholar] [CrossRef] [PubMed]
[12] 刘佳, 白玉贤, 魏孝礼. 甲胎蛋白阳性胃癌相关基因及治疗的研究进展[J]. 中国肿瘤, 2018, 27(6): 442-447.
[13] 方瑜, 王琳, 李桂梅, 张瑜, 杨宁蓉, 秦叔逵. c-Met、VEGF、EGFR和HER-2在AFP阳性胃癌中的表达研究[J]. 中国癌症杂志, 2016, 26(8): 662-669.
[14] Zhou, F., Shang, W., Yu, X. and Tian, J. (2018) Glypican-3: A Promising Biomarker for Hepatocellular Carcinoma Diagnosis and Treatment. Medicinal Research Reviews, 38, 741-767. [Google Scholar] [CrossRef] [PubMed]
[15] Matsumoto, K., Ueyama, H., Matsumoto, K., et al. (2016) Clinicopathological Features of Alpha-Fetoprotein Producing Early Gastric Cancer with Enteroblastic Differentiation. World Journal of Gastroenterology, 22, 8203-8210. [Google Scholar] [CrossRef] [PubMed]
[16] Iwaya, M., Riddell, R., Asano, K., Kobayashi, K., Uehara, T. and Ota, H. (2020) Alpha-Fetoprotein-Producing Early Gastric Cancer with Intramucosal Hepatoid and Fetal Enteric Dif-ferentiation. Case Reports in Gastroenterology, 14, 426-435. [Google Scholar] [CrossRef] [PubMed]
[17] 杨建, 周业江. AFP阳性胃癌多药耐药蛋白水平的研究[J]. 胃肠病学和肝病学杂志, 2017, 26(12): 1365-1369.
[18] Ren, F., Weng, W., Zhang, Q., Tan, C., et al. (2019) Clinicopathological Features and Prognosis of AFP-Producing Colorectal Cancer: A Single-Center Analysis of 20 Cases. Cancer Management and Research, 11, 4557-4567. [Google Scholar] [CrossRef] 
[19] Forghanifard, M.-M., Moghbeli, M., Raeisossadati, R., et al. (2013) Role of SALL4 in the Progression and Metastasis of Colorectal Cancer. Journal of Biomedical Science, 20, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[20] 谢继光, 闫晓晓, 董永红. 甲胎蛋白阳性胃癌研究现状与进展[J]. 中国临床研究, 2019, 32(12): 1727-1730.
[21] He, L., Ye, F., Qu, L., et al. (2016) Protein Profiling of Al-pha-Fetoprotein Producing Gastric Adenocarcinoma. Oncotarget, 7, 28448-28459. [Google Scholar] [CrossRef] [PubMed]
[22] Søreide, J.A., Greve, O.J., Gudlaugsson, E. and Størset, S. (2016) Hepatoid Adenocarcinoma of the Stomach—Proper Identification and Treatment Remain a Challenge. Scandinavian Journal of Gastroenterology, 51, 646-653. [Google Scholar] [CrossRef] [PubMed]
[23] Anzai, H., Kazama, S., Kiyomatsu, T., et al. (2015) Al-pha-Fetoprotein-Producing Early Rectal Carcinoma: A Rare Case Report and Review. World Journal of Surgical On-cology, 13, Article No. 180. [Google Scholar] [CrossRef] [PubMed]
[24] 沈洪章, 朱家沂, 于鸿, 杨斌. 产甲胎蛋白胰腺癌一例并文献复习[J]. 中华全科医师杂志, 201, 11(10): 796-797.
[25] 张永一, 葛军辉, 蔡洪培. 产甲胎蛋白胰腺癌二例及文献复习[J]. 中华胰腺病杂志, 2011, 11(11): 61-63.
[26] Akturk, G., Sagol, O., Unek, T., et al. (2018) Al-pha-Fetoprotein-Secreting Gallbladder Carcinoma: A Case Report. Journal of Gastrointestinal Cancer, 49, 528-531. [Google Scholar] [CrossRef] [PubMed]
[27] Dixit, N., Trivedi, S. and Bansal, V.K. (2021) Clear-Cell Ade-nocarcinoma of the Gallbladder with Alpha-Fetoprotein Production: A Case Report and Review of the Literature. Gas-trointestinal Tumors, 8, 52-57. [Google Scholar] [CrossRef] [PubMed]
[28] Kong, X.-X., Li, X.-L., Tian, Y., et al. (2021) The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract—A Single-Center Ret-rospective Study. Frontiers in Oncology, 11, Article 635537. [Google Scholar] [CrossRef] [PubMed]
[29] He, R., Yang, Q., Dong, X., Wang, Y., Zhang, W., et al. (2017) Clinicopathologic and Prognostic Characteristics of Al-pha-Fetoprotein-Producing Gastric Cancer. Oncotarget, 8, 23817-23830. [Google Scholar] [CrossRef] [PubMed]
[30] 徐军, 王健, 陈君平, 等. 伴血清甲胎蛋白升高的胃癌32例临床病理特征[J]. 临床与实验病理学杂志, 2021, 37(5): 600-603.
[31] 黄玉英, 柯莹, 魏晓珠. PDGF、BNP、AFP-L3在乙型肝炎肝硬化患者预后评估中的价值[J]. 热带医学杂志, 2019, 19(4): 477-480, 封3.
[32] Longo, R., Carassou, P., Leguay, C., et al. (2021) A 50-Year-Old Man with Fulminant Alpha-Fetoprotein-Producing Gastric Car-cinoma and Disseminated Intravascular Coagulation. American Journal of Case Reports, 22, e928369. [Google Scholar] [CrossRef] 
[33] 杨燕峰, 董雪伟. 阿帕替尼治疗中晚期胃癌的临床疗效及预后影响因素[J]. 实用癌症杂志, 2017, 32(8): 1318-1320.
[34] Lin, Y., Zhai, E., Liao, B., Xu, L., et al. (2017) Autocrine VEGF Signaling Promotes Cell Proliferation through a PLC-Dependent Pathway and Modulates Apatinib Treatment Efficacy in Gastric Cancer. Oncotarget, 8, 11990-12002. [Google Scholar] [CrossRef] [PubMed]
[35] Lu, J., Ding, Y., Chen, Y., et al. (2021) Whole-Exome Sequencing of Alpha-Fetoprotein Producing Gastric Carcinoma Reveals Genomic Profile and Therapeutic Targets. Nature Communications, 12, Article No. 3946. [Google Scholar] [CrossRef] [PubMed]
[36] Nakamura, Y., Matsuda, K., Yokoyama, S., et al. (2018) Al-pha-Fetoprotein-Producing Rectal Cancer Successfully Responded to Preoperative Chemoradiotherapy: Case Report. Surgical Case Reports, 4, Article No. 111. [Google Scholar] [CrossRef] [PubMed]
[37] Kim, C.Y., Lee, S.H., Jeon, H.M., et al. (2014) AFP-Producing Acinar Cell Carcinoma Treated by Pancreaticoduodenectomy in a Patient with a Previous Radical Subtotal Gastrectomy by Gastric Cancer. Korean Journal of Hepato-Biliary-Pancreatic Surgery, 18, 33-37. [Google Scholar] [CrossRef] [PubMed]
[38] 丁平安, 杨沛刚, 田园, 等. 血清甲胎蛋白阳性胃癌患者的临床病理学特征及预后分析[J]. 中国癌症杂志, 2020, 30(11): 887-896.
[39] Wang, R., Li, J., Xu, D., Li, R. and Gong, P. (2020) Dynamic Change in Serum Alpha-Fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-Fetoprotein-Producing Gastric Cancer. Medicine, 99, e23326. [Google Scholar] [CrossRef] 
[40] Reim, D., Choi, Y.-S., Yoon, H.-M., et al. (2017) Al-pha-Fetoprotein Is a Significant Prognostic Factor for Gastric Cancer: Results from a Propensity Score Matching Analysis after Curative Resection. European Journal of Surgical Oncology, 43, 1542-1549. [Google Scholar] [CrossRef] [PubMed]
[41] Wang, Y.-K., Shen, L., Jiao, X. and Zhang, X.-T. (2018) Predictive and Prognostic Value of Serum AFP Level and Its Dynamic Changes in Advanced Gastric Cancer Patients with Elevated Serum AFP. World Journal of Gastroenterology, 24, 266-273. [Google Scholar] [CrossRef] [PubMed]
[42] Natsume, T., Watanabe, Y., Maruyama, T., Tanaka, H., et al. (2005) Successful Resection of a Liver Metastasis from AFP-Producing Pancreatic Cancer Resulting in Long-Term Survival. Pancreas, 31, 416-419. [Google Scholar] [CrossRef] [PubMed]
[43] Zhu, X., Yong, H., Zhang, L., et al. (2015) Pure Al-pha-Fetoprotein-Producing Neuroendocrine Carcinoma of the Pancreas: A Case Report. BMC Gastroenterology, 15, Article No. 16. [Google Scholar] [CrossRef] [PubMed]

为你推荐